Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

PULSE Registry Subanalysis: Radial vs. Femoral Secondary Access

In view of its lower complications rate, the transfemoral approach is the most used in transcatheter aortic valve replacement (TAVR), vs. alternative access sites. In addition to a primary access for device deployment, a secondary access is needed for pigtail catheter placement to guide prosthesis implantation. In most cases, a second transfemoral puncture is performed for secondary access.  

However, current evidence has associated secondary access with higher risk of access-related vascular complications. The transradial approach appears safer vs. the transfemoral; still, there are no specific studies assessing its impact on secondary access.  

The aim of this PULSE (retrospective and multicenter) subanalysis was to evaluate the incidence of secondary access related vascular complications after transradial (TRSA) vs transfemoral (TFSA) in TAVR. 

Read also: Direct Oral Anticoagulants for Ventricular Thrombus After STEMI.

The primary outcome was the incidence of major and minor secondary-access-related vascular complications. These complications were classified into bleeding, stenosis/occlusion, dissection and pseudoaneurysm. 

8,851 patients were looked at, 1,686 (19%) received TRSA and 7,165 (81%) TFSA. For sample homogenization, propensity analysis was carried out, resulting in 512 patients in each group. Mean patient age was 82, and 49.1% were women. 

Secondary access vascular complications occurred in 0,3 % of TRSA patients vs. 3,2 % of TFSA patients (P < 0,001), and were considered major in 0,2 % of TRSA and 1,5 % of TFSA patients, and minor in 0,1 % and 1,7 %, respectively (P < 0,001 for both). No TRSA patient required surgical repair, while 0,9 % of TFSA patients did require intervention. 

Read also: FAVOR III Europa Sub-Analysis: Coronary Revascularization Deferral Based On QFR vs FFR.

On the other hand, primary access vascular complications were similar between groups, with an incidence of 11,6 % in TRSA and 11,5 % in TFSA patients (P = 0,93). However, type III/IV bleeding was less frequent among TRSA patients (2,5 %) vs TFSA (4,7 %) (P < 0,001). After sample homogenization, secondary access related complication rate was 0,2 % for TRSA vs 2,9 % for TFSA (P < 0,001). 

Conclusion: Transradial (TRSA) vs. Transfemoral Approach (TFSA) in TAVR: Safer with Fewer Complications 

TAVR patients treated via femoral approach, the use of, the use of TRSA was associated with lower access-related complications rate, vs. TFSA. These findings suggest that the transradial access can be considered safe vs. the femoral, for secondary access. 

Original Title: Femoral or Radial Secondary Access in TAVR A Subanalysis from the Multicenter PULSE Registry.

Reference: David Grundmann MD et al JACC Cardiovasc Interv.2024;17:2923–2932.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Dr. Omar Tupayachi
Dr. Omar Tupayachi
Member of the Editorial Board of solaci.org

More articles by this author

SCAI 2026 | Can an atrial fixation device prevent complications of transcatheter mitral valve replacement? Analysis of the AltaValve system

Transcatheter mitral valve replacement (TMVR) represents one of the most complex areas within structural interventions. Unlike TAVI, where valvular anatomy typically provides more predictable...

Beyond TAVI: Cardiac Rehabilitation as a Determinant of Clinical Outcomes

Aortic stenosis is an increasingly prevalent condition associated with population aging, with a prevalence of approximately 3.4% in individuals over 75 years of age...

Comparative outcomes between transaxillary approach and thoracotomy-based approaches in TAVI with alternative access

TAVI has become the standard treatment for high-risk aortic stenosis. When transfemoral access is not feasible (approximately 10–15%), alternative approaches are used: transaxillary (subclavian...

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

SCAI 2026 | Deep vein arterialization as an alternative in patients with critical limb ischemia without conventional options

Critical limb ischemia (CLI) represents one of the most advanced stages of peripheral arterial disease (PAD). In a significant proportion of patients, distal anatomy,...

SCAI 2026 | Can an atrial fixation device prevent complications of transcatheter mitral valve replacement? Analysis of the AltaValve system

Transcatheter mitral valve replacement (TMVR) represents one of the most complex areas within structural interventions. Unlike TAVI, where valvular anatomy typically provides more predictable...

SCAI 2026 | SELUTION DeNovo subanalysis: Use of sirolimus-eluting balloon in acute coronary syndrome

Percutaneous coronary intervention (PCI) with drug-eluting stent (DES) implantation remains the predominant strategy in the setting of acute coronary syndrome (ACS). However, in recent...